ArticleNature communications2024

Etrolizumab-s fails to control E-Cadherin-dependent co-stimulation of highly activated cytotoxic T cells.

Maximilian Wiendl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.